COVID-19 News

View our latest news about advancements in health science, COVID-19, and more.

Oct 1 2021

Labcorp Receives Emergency Use Authorization for At Home Collection Kit for Combined COVID-19 and Flu Detection

BURLINGTON, N.C., October 1, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined home collection kit that detects COVID-19 and influenza A/B simultaneously in individuals as young as 2 years of age. The kit will be available at no upfront cost to those who meet clinical guidelines, which may include experiencing symptoms, being exposed to someone with COVID-19 or if asked to be tested by a health care provider. 

Read more »
Jul 1 2021

Labcorp Extends COVID-19 Genomic Sequencing Work With The CDC

BURLINGTON, N.C., June 30, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced the extension of its work with the U.S. Centers for Disease Control and Prevention (CDC) to help identify and monitor variants of SARS-CoV-2, the virus that causes COVID-19. 

Read more »
Jun 22 2021

Labcorp Adopts Molecular Loop SARS-CoV-2 Research Sequencing Panel for Large-Scale Viral Surveillance

Molecular Loop Biosciences, Inc. , a company redefining the simplicity of targeted sequencing, announced today that its SARS-CoV-2 Research Sequencing Panel has been deployed by Labcorp (NYSE: LH), a leading global life sciences company, to help sequence thousands of complete coronavirus genomes each week from positive patient samples. This sequencing is being performed as part of a U.S. Centers for Disease Control and Prevention (CDC) effort to identify and track the spread of SARS-CoV-2 variants throughout the country.

Read more »
Jun 16 2021

NCDHHS Expands Home Testing Program to All Eligible North Carolinians

The North Carolina Department of Health and Human Services today announced the state is expanding availability of its at-home COVID-19 test collection. Any North Carolina resident may receive a Pixel by Labcorp® COVID-19 PCR Test Home Collection Kit that is shipped overnight directly to their homes at no cost. Tests can be used on people age 2 and up.

Read more »
May 25 2021

Labcorp Study Suggests COVID-19 Antibodies Remain at Least 10 Months After Infection

BURLINGTON, N.C.--(BUSINESS WIRE)--May 24, 2021-- Nearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2 proteins for at least 10 months, according to a new Labcorp (NYSE: LH) analysis of specimens from 39,086 individuals.

Read more »
May 13 2021

Pixel by Labcorp COVID-19 PCR Test Home Collection Kit Receives FDA Emergency Authorization for Ages 2-17

BURLINGTON, N.C., May 13, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Pixel by Labcorp COVID-19 PCR Test Home Collection Kit for ages 2-17. The authorization expands the use of Pixel by Labcorp to children and adolescents 2 years of age and older when purchased by a parent or guardian. 

Read more »
May 11 2021

Labcorp and the U.S. Department of Health and Human Services Join Forces to Raise Awareness of COVID-19 Treatments

BURLINGTON, N.C., May 11, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, is working with the U.S. Department of Health and Human Services (HHS) to raise awareness of potentially lifesaving monoclonal antibody COVID-19 therapies. 

Read more »
Apr 20 2021

Labcorp Launches COVID-19 Test Kits For Small Businesses to Support Return to Work and Life Safely

BURLINGTON, N.C. — Labcorp (NYSE: LH), a leading global life sciences company, today announced the availability of the Pixel by Labcorp® COVID-19 PCR Test Home Collection Kit for small businesses, an initiative aimed at providing fast, convenient, and reliable testing for companies with as many as 120 employees. Labcorp Employer Services currently provides COVID-19 testing and vaccination services for larger organizations and communities. 

Read more »
Mar 26 2021

NCDHHS Pilots Home Testing Program with Labcorp to Increase Access to Testing

RALEIGH — While vaccine supplies are limited, it is important North Carolinians continue practicing the 3Ws and get tested for COVID-19 if they have symptoms or have been in close contact to someone with COVID-19.

Read more »
Feb 24 2021

Walgreens to Make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at Stores Nationwide

Kit to be available for purchase at Walgreens without a prescription and will allow for greater access to testing, helping reduce the spread of COVID-19 and improve the health of communities

Read more »
Feb 24 2021

Natick, Massachusetts Mass Vaccination Site | Opening Remarks | Bill Haas, senior vice president, Northeast Division, Labcorp

Thank you for joining us today at our mass vaccination site here at the Natick Mall. I’m Bill Haas, senior vice president of the northeast division at Labcorp. We’re thrilled to be working across the commonwealth to make it easier for people to get tested and vaccinated, as we all work together to slow the spread of COVID-19. 

Read more »
Feb 19 2021

Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19

Labcorp Using PacBio’s HiFi Sequencing to Detect SARS-CoV-2 Variants in the U.S.

Read more »
Feb 17 2021

Labcorp Adds High Sensitivity Antigen Test to Screen for Active COVID-19 Infection

Antigen Test Is the Latest Offering by Labcorp to Fight COVID-19 at Every Stage, from Diagnostic Testing to Clinical Trials and Vaccination Services

Read more »

Labcorp's COVID-19 PCR Testing

1-2 Days

Average Time to Result from Specimen Pickup

45M

Molecular tests performed

275K

Molecular test capacity per day**

5.5M

Antibody tests performed

300K

Antibody test  capacity per day**

$0

Tests Offered with No Upfront Costs*

Tracking COVID-19 Variants

We have been regularly tracking variants of the virus throughout the pandemic. The sensitivity of our PCR test is not impacted by these variants.

Labcorp PCR Test Performance Confirmed

Checkmark
Alpha (B.1.1.7, Q.1-Q.8)
Checkmark
Beta (B.1.351, B.1.351.2, B.1.351.3)
Checkmark
Delta (B.1.617.2)
Checkmark
Epsilon (B.1.427, B.1.429)
Checkmark
Eta (B.1.525)
Checkmark
Gamma (P.1, P.1.1, P.1.2) 
Checkmark
Iota (B.1.526)
Checkmark
Kappa (B.1.617.1)
Checkmark
Lambda (C.37)
Checkmark
Mu (B.1.621)
Checkmark
Zeta (P.2)

Labcorp has been working with the Centers for Disease Control and Prevention (CDC) to provide sequencing of samples of SARS-CoV-2, the virus that causes COVID-19.

For more information visit US COVID-19 Cases Caused by Variants on the CDC website. 


Media Information

For Media Inquiries


Christopher Allman-Bradshaw
or Rachael Valdez
Phone: 336-436-8263
Email: [email protected]

For Investor Relations


Chas Cook
Phone: 336-436-5076
Email: [email protected]

Digital Assets


If you use any of this imagery or footage, please use Photo/Video credit: Labcorp
Download B-roll
Download Images